Patient-centric Head and Neck Care
Complications of head and cancer therapy are common in survivors and continue indefinitely and dental and oral , swallowing, depression and nutritional complications increase overtime following therapy. As complications can occur years following therapy, it is important that head and neck practitioners recognize these complications and need for prevention, follow-up and early management. Experts in the fields of dental, swallowing, psychologists and nutritionists will educate us on these needs.
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.
Upon completion of this activity, participants should be able to do the following:
- Identify depression as a predictor of head and neck cancer overall survival, mediated by tumor treatment response and activity/sleep disturbance, along with some emerging data showing similar outcome relationships with anxiety.
- Determine ways to prevent long term oral complications of head and neck cancer treatment.
- Describe prophylactic ways to prevent or decrease long term dysphagia complications.
Heather Starmer, MA CCC-SLP, BCS-S, is employed by Stanford University and has no financial relationships with a commercial interest.
Joel Epstein, DMD, MSD, is employed by Cedars-Sinai Medical Center and receives research grants from City of Hope.
Elizabeth Cash, PhD, is employed by the University of Louisville and has no financial relationships with a commercial interest.
Devin Okay, DDS, is employed by Mount Sinai Hospital and has no financial relationships with a commercial interest.
Gloria Rubio, MBA, MS, is employed by the University of California, San Diego and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.